Biostar Microtech International Corp.(TW:2399)
NT$42.95+0.80 (+1.90%)
TW:2399
Biostar Microtech International Corp. financials statements
NT$42.95
At close:+0.80 (+1.90%)
Biostar Microtech International Corp. (2399) Ratios
Biostar Microtech International Corp. Ratios
TW:2399's free cash flow for Q2 2026 was NT$15.36M. For the 2026 fiscal year, TW:2399's free cash flow was decreased by NT$-4.00K and operating cash flow was NT$15.36M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.61 | 5.38 | 3.77 | 4.28 | 3.30 |
| Quick Ratio | 4.65 | 4.38 | 2.44 | 2.56 | 2.08 |
| Cash Ratio | 2.20 | 2.25 | 1.15 | 1.42 | 0.79 |
| Solvency Ratio | 0.07 | 0.03 | -0.17 | 0.03 | 0.43 |
| Operating Cash Flow Ratio | -0.25 | 0.17 | 0.11 | -0.15 | 0.11 |
| Short-Term Operating Cash Flow Coverage | -74.95 | 45.46 | 34.57 | -30.69 | 28.43 |
| Net Current Asset Value | NT$ 1.71B | NT$ 1.69B | NT$ 1.64B | NT$ 1.68B | NT$ 1.88B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.19 | 1.21 | 1.30 | 1.25 | 1.36 |
| Debt Service Coverage Ratio | -113.69 | 7.03 | -52.49 | 7.12 | 112.48 |
| Interest Coverage Ratio | -3103.80 | -911.63 | -842.90 | 140.24 | 7644.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.01 | 0.02 | 0.04 | 0.02 |
| Net Debt to EBITDA | 5.62 | -27.00 | 6.24 | -32.28 | -1.57 |
| Profitability Margins | |||||
| Gross Profit Margin | 6.46% | 8.22% | 5.77% | 12.01% | 18.74% |
| EBIT Margin | -8.77% | 1.40% | -4.98% | 0.73% | 14.66% |
| EBITDA Margin | -8.57% | 1.63% | -4.72% | 1.03% | 14.88% |
| Operating Profit Margin | -8.77% | -5.24% | -5.54% | 0.78% | 13.77% |
| Pretax Profit Margin | 1.56% | 1.40% | -4.99% | 0.72% | 14.66% |
| Net Profit Margin | 1.51% | 0.33% | -4.84% | 0.57% | 13.03% |
| Continuous Operations Profit Margin | 1.51% | 0.33% | -4.84% | 0.57% | 13.03% |
| Net Income Per EBT | 96.68% | 23.50% | 96.87% | 79.29% | 88.90% |
| EBT Per EBIT | -17.79% | -26.64% | 90.15% | 92.45% | 106.45% |
| Return on Assets (ROA) | 1.00% | 0.25% | -4.06% | 0.46% | 10.97% |
| Return on Equity (ROE) | 1.19% | 0.31% | -5.28% | 0.57% | 14.88% |
| Return on Capital Employed (ROCE) | -6.78% | -4.77% | -5.95% | 0.77% | 15.50% |
| Return on Invested Capital (ROIC) | -6.55% | -1.12% | -5.75% | 0.61% | 13.76% |
| Return on Tangible Assets | 1.00% | 0.36% | -4.06% | 0.60% | 14.12% |
| Earnings Yield | 0.57% | 0.15% | -2.62% | 0.54% | 8.26% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.06 | 8.18 | 14.53 | 19.44 | 20.30 |
| Payables Turnover | 9.50 | 7.34 | 4.74 | 5.74 | 4.29 |
| Inventory Turnover | 4.46 | 4.68 | 2.73 | 2.18 | 2.21 |
| Fixed Asset Turnover | 13.25 | 15.18 | 17.75 | 16.48 | 20.87 |
| Asset Turnover | 0.66 | 0.77 | 0.84 | 0.80 | 0.84 |
| Working Capital Turnover Ratio | 0.99 | 1.18 | 1.38 | 1.23 | 1.52 |
| Cash Conversion Cycle | 88.73 | 72.82 | 81.79 | 122.52 | 98.16 |
| Days of Sales Outstanding | 45.26 | 44.60 | 25.12 | 18.77 | 17.98 |
| Days of Inventory Outstanding | 81.88 | 77.93 | 133.70 | 167.39 | 165.21 |
| Days of Payables Outstanding | 38.41 | 49.71 | 77.02 | 63.64 | 85.04 |
| Operating Cycle | 127.14 | 122.53 | 158.81 | 186.16 | 183.19 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.54 | 0.39 | 0.37 | -0.45 | 0.51 |
| Free Cash Flow Per Share | -0.55 | 0.36 | 0.36 | -0.47 | 0.50 |
| Dividend Paid and CapEx Coverage Ratio | -62.30 | 12.65 | 92.09 | -0.37 | 1.24 |
| Capital Expenditure Coverage Ratio | -62.30 | 12.65 | 92.09 | -38.49 | 39.67 |
| Operating Cash Flow Coverage Ratio | -74.95 | 37.43 | 16.53 | -12.72 | 28.43 |
| Operating Cash Flow to Sales Ratio | -0.05 | 0.03 | 0.03 | -0.04 | 0.03 |
| Free Cash Flow Yield | -2.11% | 1.39% | 1.49% | -3.50% | 2.04% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 174.33 | 686.83 | -38.13 | 184.21 | 12.12 |
| Price-to-Sales (P/S) Ratio | 2.63 | 2.25 | 1.84 | 1.06 | 1.58 |
| Price-to-Book (P/B) Ratio | 2.07 | 2.10 | 2.01 | 1.05 | 1.80 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -47.30 | 71.93 | 67.01 | -28.59 | 49.11 |
| Price-to-Operating Cash Flow Ratio | -48.06 | 66.25 | 66.29 | -29.33 | 47.87 |
| Price-to-Earnings Growth (PEG) Ratio | 0.57 | -6.49 | 0.04 | -1.91 | 0.08 |
| Enterprise Value Multiple | -25.07 | 110.98 | -32.78 | 70.85 | 9.04 |
| Enterprise Value | 3.73B | 3.66B | 3.63B | 1.63B | 3.73B |
| EV to EBITDA | -25.07 | 110.98 | -32.78 | 70.85 | 9.04 |
| EV to Sales | 2.15 | 1.81 | 1.55 | 0.73 | 1.34 |
| EV to Free Cash Flow | -38.64 | 57.86 | 56.30 | -19.64 | 41.83 |
| EV to Operating Cash Flow | -39.26 | 53.28 | 55.69 | -20.15 | 40.78 |
| Tangible Book Value Per Share | 12.62 | 10.80 | 12.11 | 11.97 | 12.88 |
| Shareholders’ Equity Per Share | 12.62 | 12.18 | 12.11 | 12.62 | 13.65 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.03 | 0.77 | 0.03 | 0.21 | 0.11 |
| Revenue Per Share | 9.94 | 11.33 | 13.24 | 12.56 | 15.58 |
| Net Income Per Share | 0.15 | 0.04 | -0.64 | 0.07 | 2.03 |
| Tax Burden | 0.97 | 0.23 | 0.97 | 0.79 | 0.89 |
| Interest Burden | -0.18 | 1.00 | 1.00 | 0.99 | 1.00 |
| Research & Development to Revenue | 0.04 | 0.04 | 0.03 | 0.03 | 0.04 |
| SG&A to Revenue | 0.11 | 0.10 | 0.08 | 0.09 | 0.08 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -3.63 | 2.44 | -0.58 | -6.28 | 0.22 |
Currency in TWD
